This is a Phase 2b/3 study. The purpose of a 2b/3 study is to learn more about the safety and effects of VX-210 in patients with acute traumatic cervical SCI. VX-210 is an investigational drug; “in
The overall purpose of this study is to assess the feasibility of a cross-country non-inferiority randomized controlled trial (RCT) comparing midline sparing decompression alone (MSDA) to usual care (decompression with fusion).
Many individuals with cervical spinal cord injury (SCI) have difficulty using their hands and arms. MyndMove is a non-invasive medical device that uses short, low energy electrical pulses with surface electrodes to cause muscle contractions to produce a full range of reaching and grasping movements, which the patient is unable to perform by him/herself.
By using MyndMove therapy to help the individual move their arms and hands as he/she attempts to carry out typical reaching and grasping movements, the individual improves their ability to perform these tasks voluntarily.
Losing the ability to walk can lead to fewer opportunities to socialize with friends and family, and participate in the community. When this happens, powered wheelchairs can provide access to homes and communities, contributing to health and well-being. Training by a qualified occupational therapist allows an individual to use a powered wheelchair safely and effectively. Learning to drive a powered wheelchair can be difficult, frustrating and time consuming for people with cognitive and physical challenges.